JP2018517398A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018517398A5 JP2018517398A5 JP2017552146A JP2017552146A JP2018517398A5 JP 2018517398 A5 JP2018517398 A5 JP 2018517398A5 JP 2017552146 A JP2017552146 A JP 2017552146A JP 2017552146 A JP2017552146 A JP 2017552146A JP 2018517398 A5 JP2018517398 A5 JP 2018517398A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- item
- linker
- bacterial cell
- gastrointestinal tract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 165
- 229920001184 polypeptide Polymers 0.000 claims description 164
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 164
- 238000000034 method Methods 0.000 claims description 152
- 230000001580 bacterial effect Effects 0.000 claims description 118
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 51
- 210000001519 tissue Anatomy 0.000 claims description 44
- 108090000623 proteins and genes Proteins 0.000 claims description 41
- 235000018102 proteins Nutrition 0.000 claims description 37
- 102000004169 proteins and genes Human genes 0.000 claims description 37
- 150000007523 nucleic acids Chemical group 0.000 claims description 36
- 241000588724 Escherichia coli Species 0.000 claims description 34
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 33
- 230000004927 fusion Effects 0.000 claims description 33
- 239000003795 chemical substances by application Substances 0.000 claims description 25
- 206010061218 Inflammation Diseases 0.000 claims description 24
- 230000004054 inflammatory process Effects 0.000 claims description 24
- 230000000845 anti-microbial effect Effects 0.000 claims description 21
- 102000004190 Enzymes Human genes 0.000 claims description 20
- 108090000790 Enzymes Proteins 0.000 claims description 20
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 20
- 230000001093 anti-cancer Effects 0.000 claims description 18
- 235000001014 amino acid Nutrition 0.000 claims description 11
- 150000001413 amino acids Chemical class 0.000 claims description 11
- 244000000010 microbial pathogen Species 0.000 claims description 10
- 208000011231 Crohn disease Diseases 0.000 claims description 6
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 3
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 claims description 3
- 201000006704 Ulcerative Colitis Diseases 0.000 claims description 3
- 239000004599 antimicrobial Substances 0.000 claims description 3
- 230000005907 cancer growth Effects 0.000 claims description 3
- 210000000981 epithelium Anatomy 0.000 claims description 3
- 230000003252 repetitive effect Effects 0.000 claims description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- 206010009944 Colon cancer Diseases 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- 235000004279 alanine Nutrition 0.000 claims description 2
- 208000029742 colonic neoplasm Diseases 0.000 claims description 2
- 238000012217 deletion Methods 0.000 claims description 2
- 230000037430 deletion Effects 0.000 claims description 2
- 230000002496 gastric effect Effects 0.000 claims description 2
- 230000002209 hydrophobic effect Effects 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 210000004347 intestinal mucosa Anatomy 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000002207 metabolite Substances 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 210000001986 peyer's patch Anatomy 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 230000008685 targeting Effects 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 20
- 101150112550 csgA gene Proteins 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000002950 deficient Effects 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000002516 radical scavenger Substances 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 description 34
- 230000007017 scission Effects 0.000 description 34
- 101000632178 Homo sapiens Homeobox protein Nkx-2.1 Proteins 0.000 description 5
- 101000845269 Homo sapiens Transcription termination factor 1 Proteins 0.000 description 5
- 101000845264 Homo sapiens Transcription termination factor 2 Proteins 0.000 description 5
- 102100031079 Transcription termination factor 1 Human genes 0.000 description 5
- 102100031080 Transcription termination factor 2 Human genes 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 4
- POIUWJQBRNEFGX-XAMSXPGMSA-N cathelicidin Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C1=CC=CC=C1 POIUWJQBRNEFGX-XAMSXPGMSA-N 0.000 description 4
- 101000939703 Xenopus laevis Twist-related protein Proteins 0.000 description 3
- 241000193163 Clostridioides difficile Species 0.000 description 2
- 108010053775 Nisin Proteins 0.000 description 2
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 2
- 239000003124 biologic agent Substances 0.000 description 2
- 102000014509 cathelicidin Human genes 0.000 description 2
- 108060001132 cathelicidin Proteins 0.000 description 2
- 239000012216 imaging agent Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- -1 lanibiotic Chemical compound 0.000 description 2
- 239000004309 nisin Substances 0.000 description 2
- 235000010297 nisin Nutrition 0.000 description 2
- SWISGLLTKITYOP-UHFFFAOYSA-N thuricin cd Chemical compound N1C(=O)CNC(=O)C(C(C)CC)NC(=O)CNC(=O)C(CCC(O)=O)NC(=O)C(CO)NC(=O)C(C(C)CC)NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)CC)NC2=O)CSC1(CO)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(C(NC(C)C(=O)N1)=O)(C(C)O)SCC2NC(=O)CNC(=O)C(C(C)CC)NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(N)=O)NC(=O)CN)CSC(C(=O)NC(CC(C)C)C(=O)NCC(O)=O)(C(C)O)NC(=O)C1CC1=CC=CC=C1 SWISGLLTKITYOP-UHFFFAOYSA-N 0.000 description 2
- 108010062877 Bacteriocins Proteins 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- LAWKVNVCUPIOMG-HWWYPGLISA-N gardimycin Chemical compound C1=CC=C2C(C[C@H](C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@H](C)C(=O)NCC(=O)N[C@H](CC)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(O)=O)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](C)NC(=O)[C@@H](CC)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)N)[C@@H](C)CC)C(C)C)=CNC2=C1 LAWKVNVCUPIOMG-HWWYPGLISA-N 0.000 description 1
- 108010070411 gardimycin Proteins 0.000 description 1
- 230000012743 protein tagging Effects 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021030187A JP7156726B2 (ja) | 2015-04-06 | 2021-02-26 | 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562143560P | 2015-04-06 | 2015-04-06 | |
| US62/143,560 | 2015-04-06 | ||
| PCT/US2016/026161 WO2016164422A2 (en) | 2015-04-06 | 2016-04-06 | Biosynthetic amyloid-based materials displaying functional protein sequences |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021030187A Division JP7156726B2 (ja) | 2015-04-06 | 2021-02-26 | 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018517398A JP2018517398A (ja) | 2018-07-05 |
| JP2018517398A5 true JP2018517398A5 (OSRAM) | 2019-05-16 |
| JP6916524B2 JP6916524B2 (ja) | 2021-08-11 |
Family
ID=57072695
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017552146A Active JP6916524B2 (ja) | 2015-04-06 | 2016-04-06 | 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料 |
| JP2021030187A Active JP7156726B2 (ja) | 2015-04-06 | 2021-02-26 | 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021030187A Active JP7156726B2 (ja) | 2015-04-06 | 2021-02-26 | 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20180258435A1 (OSRAM) |
| EP (1) | EP3280397A4 (OSRAM) |
| JP (2) | JP6916524B2 (OSRAM) |
| WO (1) | WO2016164422A2 (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014176311A1 (en) | 2013-04-23 | 2014-10-30 | President And Fellows Of Harvard College | Genetic reprogramming of bacterial biofilms |
| JP6916524B2 (ja) | 2015-04-06 | 2021-08-11 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料 |
| US11098133B2 (en) | 2016-05-19 | 2021-08-24 | President And Fellows Of Harvard College | Methods of making gels and films using curli nanofibers |
| FR3099648B1 (fr) * | 2019-07-30 | 2023-01-13 | Centre Nat Rech Scient | Membrane échangeuse d’ions |
| CN110585482B (zh) * | 2019-08-02 | 2022-03-01 | 大连理工大学 | 一种具有抗菌性能的杂萘联苯聚芳醚腈及其表面改性方法 |
| CN112608876B (zh) * | 2020-12-30 | 2024-02-09 | 江苏大学 | 一种生物素化Curli蛋白的活细胞标记方法及其应用 |
| GB202216905D0 (en) * | 2022-11-11 | 2022-12-28 | Oxford Nanopore Tech Plc | Novel pore monomers and pores |
| KR102855274B1 (ko) * | 2022-12-06 | 2025-09-08 | 충남대학교산학협력단 | strep-tag 결합물질에 대한 결합능을 가지는 융합단백질을 암호화하는 유전자 구조물 및 이를 함유하는 발현벡터, 재조합 균주 및 항암 조성물 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5762620A (en) | 1992-04-02 | 1998-06-09 | Ndm Acquisition Corp. | Wound dressing containing a partially dehydrated hydrogel |
| US6864365B1 (en) * | 1999-04-05 | 2005-03-08 | Innovation And Development Corporation, University Of Victoria | Bacterial fimbrial system for presentation of heterologous peptide sequences |
| EP1432729B1 (en) * | 2001-07-02 | 2008-11-12 | Merrion Research III Limited | Peyers's patch and/or m-cell targeting ligands |
| WO2003068934A2 (en) | 2002-02-14 | 2003-08-21 | Rutter William J | Chimeric molecules for cleavage in a treated host |
| NZ543288A (en) | 2003-04-30 | 2009-06-26 | Univ Drexel | Thermogelling polymer blends for biomaterial applications |
| CA2599723A1 (en) | 2005-03-04 | 2006-09-14 | Biorexis Pharmaceutical Corporation | Modified transferrin fusion proteins |
| CA2675115C (en) * | 2007-01-12 | 2014-12-09 | Actogenix N.V. | Lactococcus promoters and uses thereof |
| JP2009073766A (ja) * | 2007-09-21 | 2009-04-09 | Otsuka Pharmaceut Co Ltd | 医薬 |
| WO2010111516A2 (en) | 2009-03-25 | 2010-09-30 | Whitehead Institute For Biomedical Research | Compositions and methods for inhibiting biofilms |
| US20110033389A1 (en) | 2009-04-29 | 2011-02-10 | Zhifeng Chen | Modified antibodies for passive immunotherapy |
| US20110108199A1 (en) | 2009-11-10 | 2011-05-12 | Tyco Healthcare Group Lp | Hemostatic Tapes and Dispensers Therefor |
| EP2977055A1 (en) * | 2010-02-16 | 2016-01-27 | Novo Nordisk A/S | Factor viii fusion protein |
| CA2830052C (en) | 2010-03-31 | 2018-10-09 | Wayne State University | Injectable dendrimer hydrogel nanoparticles |
| KR20110111594A (ko) | 2010-04-05 | 2011-10-12 | 서울대학교산학협력단 | 알파-시뉴클레인 유래 곱슬 아밀로이드 섬유의 제조방법, 이를 이용한 하이드로젤의 제조 방법 및 그 이용 방법 |
| US8741417B2 (en) | 2010-04-16 | 2014-06-03 | Korea University Research And Business Foundation | Films having switchable reflectivity |
| US9095558B2 (en) | 2010-10-08 | 2015-08-04 | Board Of Regents, The University Of Texas System | Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications |
| CN103429742A (zh) * | 2010-10-15 | 2013-12-04 | 康奈尔大学 | 用于治疗内分泌、胃肠或自体免疫性疾病的组合物和方法 |
| KR20120060442A (ko) | 2010-12-02 | 2012-06-12 | 가톨릭대학교 산학협력단 | 위암 진단용 마커로서 ｔｆｆ2의 용도 |
| JP6054371B2 (ja) * | 2011-04-06 | 2016-12-27 | ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム | 病原性疾患における細菌ｍａｍポリペプチドの調節 |
| US9580480B2 (en) * | 2011-05-31 | 2017-02-28 | Massachusetts Institute Of Technology | Cell-directed synthesis of multifunctional nanopatterns and nanomaterials |
| JP6006309B2 (ja) * | 2011-07-08 | 2016-10-12 | アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc | 作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド |
| CA2880791A1 (en) | 2011-08-03 | 2013-02-07 | Children's Medical Center Corporation | A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin |
| US9814756B2 (en) | 2012-06-15 | 2017-11-14 | Temple University—Of the Commonwealth System of Higher Education | Use of isolated bacterial amyloids for treatment of inflammatory disorders or diseases of the epithelium |
| WO2014018572A2 (en) * | 2012-07-23 | 2014-01-30 | Zymeworks Inc. | Immunoglobulin constructs comprising selective pairing of the light and heavy chains |
| US20150291991A1 (en) | 2012-11-16 | 2015-10-15 | President And Fellows Of Harvard College | Methods and compositions relating to amyloidogenic polypeptides |
| CA2898100C (en) * | 2013-01-14 | 2023-10-10 | Xencor, Inc. | Novel heterodimeric proteins |
| JP2014156428A (ja) * | 2013-02-15 | 2014-08-28 | Univ Of Tokyo | 抗体結合タンパク質 |
| WO2014139468A1 (en) * | 2013-03-15 | 2014-09-18 | Admark Healthcare, Llc | Fusion protein molecules and method of use |
| WO2014176311A1 (en) * | 2013-04-23 | 2014-10-30 | President And Fellows Of Harvard College | Genetic reprogramming of bacterial biofilms |
| US10179194B2 (en) | 2013-11-30 | 2019-01-15 | Agency For Science, Technology And Research | Self-assembling peptides, peptidomimetics and peptidic conjugates as building blocks for biofabrication and printing |
| WO2015097289A1 (en) | 2013-12-24 | 2015-07-02 | Vib Vzw | Secretion and functional display of chimeric polypeptides |
| US20150342893A1 (en) | 2014-05-29 | 2015-12-03 | Sigmoid Pharma Limited | Celecoxib formulations useful for treating colorectal cancer |
| JP6916524B2 (ja) | 2015-04-06 | 2021-08-11 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料 |
| US11098133B2 (en) | 2016-05-19 | 2021-08-24 | President And Fellows Of Harvard College | Methods of making gels and films using curli nanofibers |
-
2016
- 2016-04-06 JP JP2017552146A patent/JP6916524B2/ja active Active
- 2016-04-06 EP EP16777174.0A patent/EP3280397A4/en active Pending
- 2016-04-06 US US15/564,619 patent/US20180258435A1/en not_active Abandoned
- 2016-04-06 WO PCT/US2016/026161 patent/WO2016164422A2/en not_active Ceased
-
2020
- 2020-02-10 US US16/785,874 patent/US11286491B2/en active Active
-
2021
- 2021-02-26 JP JP2021030187A patent/JP7156726B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018517398A5 (OSRAM) | ||
| Bédard et al. | Recent progress in the chemical synthesis of class II and S-glycosylated bacteriocins | |
| Zheng et al. | Development of an amino acid‐functionalized fluorescent nanocarrier to deliver a toxin to kill insect pests | |
| Kosikowska et al. | Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015) | |
| AU2014321161B2 (en) | Silica micro- and nano-capsules and methods for making them | |
| Kang et al. | Recent research progress of biologically active peptides | |
| Makhlynets et al. | Characteristics and therapeutic applications of antimicrobial peptides | |
| CN104341497B (zh) | 一种新型猪源抗菌肽突变体及其制备方法和应用 | |
| Jiang et al. | Recombinant expression of porcine lactoferrin peptide LF-6 with intein technology and its immunomodulatory function in ETEC K88-infected mice | |
| CN106146643B (zh) | 人α‑防御素5改造体及其应用 | |
| CN114989254B (zh) | 一种多肽及其设计方法和在制备抑制具核梭杆菌产品或预防结直肠癌药物中的应用 | |
| WO2019213105A1 (en) | Methods and compositions involving plantaricin ef (plnef) | |
| CN101307100A (zh) | 一种抗菌肽的多肽片段及其核苷酸序列和应用 | |
| Zhang et al. | Soluble expression and purification of recombinant bovine ferritin H-chain | |
| WO2021073131A1 (zh) | 高效杀灭耐药病害菌的药物及在抑制耐药病害菌中的应用 | |
| CN116529357A (zh) | 用于细菌表面展示的融合蛋白 | |
| CN112552389B (zh) | 一种活性肽融合蛋白及其制备方法 | |
| CN111848817B (zh) | 一种兼具抗菌、抗病毒、免疫调节和抗炎活性的多功能杂合肽及其制备方法和应用 | |
| CN106749534A (zh) | 一种许氏平鮋抗菌肽bs20及其应用 | |
| CN114249839A (zh) | 一种ⅲ型胶原蛋白的融合蛋白、表达系统、药物组合物及应用 | |
| TWI353252B (en) | Biologically active peptide vapeehptllteaplnpk der | |
| TW201723174A (zh) | 重組蛋白質的製造方法 | |
| CN115724924A (zh) | 一种可自组装成胶的重组类胶原蛋白及其制备方法与应用 | |
| CN107827988B (zh) | 嵌合穿膜抗菌肽t11n2及其应用 | |
| JP5673596B2 (ja) | 細胞膜透過性を有する製剤及び細胞膜透過性組成物 |